SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurex Corporation -- Ignore unavailable to you. Want to Upgrade?


To: Tagore who wrote (419)3/13/1998 3:00:00 AM
From: cur  Read Replies (1) | Respond to of 449
 
Any news on when results from Head Trauma (measures
the application of Ziconotide as a neuronal protectant
during an ischemic episode) are due out?
Any rumors or thoughts as to how these trials are going?



To: Tagore who wrote (419)3/13/1998 7:49:00 PM
From: Roland Chen  Respond to of 449
 
<<NXCO will report preliminary malignant pain results in the first two weeks of April and file an NDA in September for expedited (six month) approval.>>
Tagore,
Where do you get that info ?
Thanks
Roland
geocities.com



To: Tagore who wrote (419)3/14/1998 10:50:00 AM
From: wendell morris  Read Replies (2) | Respond to of 449
 
Are we missing something?
check this out....http://biz.yahoo.com/bw/980313/informed_i_1.html